年轻卒中与卒中后数年新发癌症的关联:荷兰患者研究
该登记与人群-based研究纳入荷兰1998年1月1日至2019年1月1日期间390 398例≥15岁、无癌症史的首发缺血性卒中或脑出血(ICH)患者,与年龄、性别、日历年匹配的一般人群比较。15至49岁患者卒中后10年新发癌症累积发生率为3.7%(95%CI 3.4%-4.0%),≥50岁者为8.5%(95%CI 8.4%-8.6%)。卒中后第一年,15至49岁患者缺血性卒中后新发癌症的标准化发病比(SIR)为2.6(95%CI 2.2-3.1),ICH后为5.4(95%CI 3.8-7.3);≥50岁患者缺血性卒中后SIR为1.2(95%CI 1.2-1.2),ICH后为1.2(95%CI 1.1-1.2)。作者认为该发现对筛查的意义尚待研究。
要点
- 15至49岁患者卒中后第一年新发癌症风险较一般人群升高:缺血性卒中SIR 2.6(95%CI 2.2-3.1),ICH SIR 5.4(95%CI 3.8-7.3)。
- ≥50岁患者卒中后第一年新发癌症风险仅轻度升高:缺血性卒中SIR 1.2(95%CI 1.2-1.2),ICH SIR 1.2(95%CI 1.1-1.2)。
- 15至49岁患者卒中后10年新发癌症累积发生率为3.7%(95%CI 3.4%-4.0%),≥50岁者为8.5%(95%CI 8.4%-8.6%)。
- 15至49岁患者中,女性卒中后新发癌症累积发生率高于男性(Gray检验统计量22.2;P<.001);≥50岁患者中男性高于女性(Gray检验统计量943.1;P<.001)。
- 作者认为年轻卒中患者卒中后第一年癌症风险升高,但是否需筛查尚待研究。
适用人群与场景
- 荷兰≥15岁、无癌症史、1998年1月1日至2019年1月1日期间首次发生缺血性卒中或ICH的患者,共390 398例。
- 15至49岁患者27 616例(中位年龄44.5岁[IQR 39.1-47.6岁];女性13 916例[50.4%];缺血性卒中22 622例[81.9%])。
- ≥50岁患者362 782例(中位年龄75.8岁[IQR 66.9-82.9岁];女性181 847例[50.1%];缺血性卒中307 739例[84.8%])。
研究设计与关键结果
- 研究类型:基于登记和人群的研究,通过荷兰人口登记、荷兰国家医院出院登记和国家死因登记 linkage 识别患者和结局,参照数据来自荷兰癌症登记。
- 主要结局:卒中后新发癌症累积发生率,按卒中亚型、年龄和性别分层,与年龄、性别和日历年匹配的一般人群比较。
- 15至49岁患者卒中后10年新发癌症累积发生率为3.7%(95%CI 3.4%-4.0%);≥50岁患者为8.5%(95%CI 8.4%-8.6%)。
- 15至49岁患者中,女性卒中后新发癌症累积发生率高于男性(Gray检验统计量22.2;P<.001);≥50岁患者中男性高于女性(Gray检验统计量943.1;P<.001)。
- 卒中后第一年,15至49岁患者缺血性卒中后新发癌症SIR为2.6(95%CI 2.2-3.1),ICH后SIR为5.4(95%CI 3.8-7.3)。
- 卒中后第一年,≥50岁患者缺血性卒中后新发癌症SIR为1.2(95%CI 1.2-1.2),ICH后SIR为1.2(95%CI 1.1-1.2)。
证据类型、等级与局限
- 证据类型:基于登记和人群的观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与一般人群相比,15至49岁卒中患者卒中后第一年癌症风险可能升高3至5倍,≥50岁患者仅轻度升高。
- 作者认为,该发现对筛查的意义尚待研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Stroke may be a first manifestation of an occult cancer or may be an indicator of an increased cancer risk in later life. However, data, especially for younger adults, are limited.
OBJECTIVES: To assess the association of stroke with new cancer diagnoses after a first stroke, stratified by stroke subtype, age, and sex, and to compare this association with that in the general population.
DESIGN, SETTING, AND PARTICIPANTS: This registry- and population-based study included 390 398 patients in the Netherlands aged 15 years or older without a history of cancer and with a first-ever ischemic stroke or intracerebral hemorrhage (ICH) between January 1, 1998, and January 1, 2019. Patients and outcomes were identified through linkage of the Dutch Population Register, the Dutch National Hospital Discharge Register, and National Cause of Death Register. Reference data were gathered from the Dutch Cancer Registry. Statistical analysis was performed from January 6, 2021, to January 2, 2022.
EXPOSURE: First-ever ischemic stroke or ICH. Patients were identified by administrative codes from the International Classification of Diseases, Ninth Revision, and the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision.
MAIN OUTCOMES AND MEASURES: The primary outcome was the cumulative incidence of first-ever cancer after index stroke, stratified by stroke subtype, age, and sex, compared with age-, sex- and calendar year-matched peers from the general population.
RESULTS: The study included 27 616 patients aged 15 to 49 years (median age, 44.5 years [IQR, 39.1-47.6 years]; 13 916 women [50.4%]; 22 622 [81.9%] with ischemic stroke) and 362 782 patients aged 50 years or older (median age, 75.8 years [IQR, 66.9-82.9 years]; 181 847 women [50.1%]; 307 739 [84.8%] with ischemic stroke). The cumulative incidence of new cancer at 10 years was 3.7% (95% CI, 3.4%-4.0%) among patients aged 15 to 49 years and 8.5% (95% CI, 8.4%-8.6%) among patients aged 50 years or older. The cumulative incidence of new cancer after any stroke among patients aged 15 to 49 years was higher among women than men (Gray test statistic, 22.2; P < .001), whereas among those aged 50 years or older, the cumulative incidence of new cancer after any stroke was higher among men (Gray test statistic, 943.1; P < .001). In the first year after stroke, compared with peers from the general population, patients aged 15 to 49 years were more likely to receive a diagnosis of a new cancer after ischemic stroke (standardized incidence ratio [SIR], 2.6 [95% CI, 2.2-3.1]) and ICH (SIR, 5.4 [95% CI, 3.8-7.3]). For patients aged 50 years or older, the SIR was 1.2 (95% CI, 1.2-1.2) after ischemic stroke and 1.2 (95% CI, 1.1-1.2) after ICH.
CONCLUSIONS AND RELEVANCE: This study suggests that, compared with the general population, patients aged 15 to 49 years who have had a stroke may have a 3- to 5-fold increased risk of cancer in the first year after stroke, whereas this risk is only slightly elevated for patients aged 50 years or older. Whether this finding has implications for screening remains to be investigated.
参考来源
- Verhoeven JI, Fan B, Broeders MJM, et al. Association of Stroke at Young Age With New Cancer in the Years After Stroke Among Patients in the Netherlands. JAMA Netw Open. 2023. PMID: 36976557. doi:10.1001/jamanetworkopen.2023.5002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。